Iberdomide plus dexamethasone for heavily pretreated multiple myeloma

Phase Ib/IIa study of iberdomide, in combination with dexamethasone, in patients with RRMMПодробнее

First clinical study of iberdomide, a CELMoD, in pts with relapsed/refractory multiple myelomaПодробнее

Iberdomide in Combination with Dex and Dara, Bort, or Cfz in Pts with RRMMПодробнее

Iberdomide in combination with dexamethasone and daratumumab, bortezomib, or carfilzomib in RRMM...Подробнее

Iberdomide + dexamethasone in R/R multiple myelomaПодробнее

Iberdomide with dexamethasone for R/R multiple myelomaПодробнее

Results of Iberdomide in Combination with Dex and Daratumumab or Bortezomib in Patients with RRMMПодробнее

Update on iberdomide treatment combinations in R/R myelomaПодробнее

Iberdomide in combination with dexamethasone for multiple myelomaПодробнее

The efficacy & role of iberdomide in R/R multiple myelomaПодробнее

Bendamustine-bortezomib-dexamethasone in heavily pretreated immunotherapy-refractory myelomaПодробнее

CC-220-MM-001: IberDd, IberVd and IbrKd for R/R myelomaПодробнее

Trial of Iberdomide, A Novel CELMoD, In Smoldering Multiple Myeloma | Nisha Joseph, MD | #ASH24Подробнее

BVD in heavily pretreated multiple myelomaПодробнее

Safety and efficacy of iberdomide + dexamethasone in patients with triple-class refractory myelomaПодробнее

Iberdomide plus dex effective and well tolerated in R/R MMПодробнее

R/R myeloma: iberdomide, dex & dara or bortezomibПодробнее

Iberdomide in Combination with DEX in pts with RRMM: Results from the CC-220-MM-001 TrialПодробнее

Iberdomide-based regimens in R/R multiple myelomaПодробнее